Pulse Biosciences (PLSE) Receivables - Net (2021 - 2025)

Pulse Biosciences' Receivables - Net history runs 3 years deep, the most recent figure standing at $274000.0 for Q4 2025.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $274000.0 in Q4 2025; TTM through Dec 2025 was $274000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $274000.0, changed N/A from the prior year.
• Receivables - Net rose to $274000.0 in Q4 2025 per PLSE's latest filing, from $15000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $274000.0 in Q4 2025 and bottomed at $5000.0 in Q3 2022.
• The 3-year median for Receivables - Net is $21000.0 (2022), against an average of $65142.9.
• Biggest YoY gain for Receivables - Net was 93.06% in 2022; the steepest drop was 93.06% in 2022.
• Year by year, Receivables - Net stood at $61000.0 in 2021, then plunged by 91.8% to $5000.0 in 2022, then jumped by 5380.0% to $274000.0 in 2025.
• Per Business Quant, the three latest PLSE Receivables - Net figures stand at $274000.0 (Q4 2025), $15000.0 (Q3 2025), and $5000.0 (Q3 2022).